Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 6
2004 13
2005 5
2006 4
2007 9
2008 14
2009 16
2010 15
2011 18
2012 27
2013 31
2014 20
2015 30
2016 24
2017 21
2018 18
2019 22
2020 24
2021 21
2022 19
2023 13
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

327 results

Results by year

Filters applied: . Clear all
Page 1
Disease-modifying therapies and cost-of-illness progression among people newly diagnosed with multiple sclerosis: a national register-based cohort study covering treatment initiation with interferons, glatiramer acetate or natalizumab.
Karampampa K, Gyllensten H, Friberg E, Murley C, Kavaliunas A, Hillert J, Olsson T, Alexanderson K. Karampampa K, et al. Among authors: alexanderson k. BMJ Open. 2023 May 16;13(5):e067516. doi: 10.1136/bmjopen-2022-067516. BMJ Open. 2023. PMID: 37192793 Free PMC article.
Trajectories of disease-modifying therapies and associated sickness absence and disability pension among 1923 people with multiple sclerosis in Sweden.
Teni FS, Machado A, Murley C, He A, Fink K, Gyllensten H, Glaser A, Alexanderson K, Hillert J, Friberg E. Teni FS, et al. Among authors: alexanderson k. Mult Scler Relat Disord. 2023 Jan;69:104456. doi: 10.1016/j.msard.2022.104456. Epub 2022 Dec 9. Mult Scler Relat Disord. 2023. PMID: 36529068 Free article.
327 results